News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
629,752 Results
Type
Article (48398)
Company Profile (196)
Press Release (581143)
Multimedia
Podcasts (165)
Webinars (22)
Section
Business (173093)
Career Advice (2546)
Deals (31999)
Drug Delivery (145)
Drug Development (76629)
Employer Resources (166)
FDA (16526)
Job Trends (13365)
News (306684)
Policy (32097)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2385)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (134)
Alliances (43481)
ALS (168)
Alzheimer's disease (1733)
Antibody-drug conjugate (ADC) (329)
Approvals (16690)
Artificial intelligence (520)
Autoimmune disease (155)
Automation (32)
Bankruptcy (325)
Best Places to Work (9915)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (97)
Bladder cancer (159)
Brain cancer (57)
Breast cancer (612)
Cancer (4662)
Cardiovascular disease (413)
Career advice (2155)
Career pathing (39)
CAR-T (266)
CDC (59)
Celiac Disease (1)
Cell therapy (737)
Cervical cancer (35)
Clinical research (65534)
Collaboration (1595)
Company closure (4)
Compensation (1159)
Complete response letters (72)
COVID-19 (2771)
CRISPR (87)
C-suite (804)
Cystic fibrosis (142)
Data (5892)
Decentralized trials (2)
Denatured (43)
Depression (147)
Diabetes (485)
Diagnostics (5826)
Digital health (36)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (237)
Drug pricing (223)
Drug shortages (35)
Duchenne muscular dystrophy (235)
Earnings (72448)
Editorial (65)
Employer branding (20)
Employer resources (147)
Events (96647)
Executive appointments (933)
FDA (19604)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (20)
Funding (1326)
Gene editing (194)
Generative AI (45)
Gene therapy (605)
GLP-1 (1090)
Government (4275)
Grass and pollen (8)
Guidances (378)
Healthcare (15549)
HIV (58)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (285)
Immuno-oncology (56)
Indications (98)
Infectious disease (3030)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (107)
Intellectual property (237)
Interviews (468)
IPO (15223)
IRA (58)
Job creations (3773)
Job search strategy (1773)
JPM (70)
Kidney cancer (16)
Labor market (82)
Layoffs (624)
Leadership (40)
Legal (7764)
Liver cancer (92)
Longevity (14)
Lung cancer (627)
Lymphoma (363)
Machine learning (40)
Management (55)
Manufacturing (780)
MASH (167)
Medical device (11802)
Medtech (11846)
Mergers & acquisitions (17814)
Metabolic disorders (1333)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (327)
Neuropsychiatric disorders (99)
Neuroscience (2969)
Neurotech (1)
NextGen: Class of 2026 (5287)
Non-profit (3345)
Now hiring (38)
Obesity (668)
Opinion (300)
Ovarian cancer (152)
Pain (201)
Pancreatic cancer (218)
Parkinson's disease (288)
Partnered (29)
Patents (487)
Patient recruitment (452)
Peanut (54)
People (52621)
Pharmaceutical (80)
Pharmacy benefit managers (32)
Phase 1 (19728)
Phase 2 (28514)
Phase 3 (22602)
Pipeline (4959)
Policy (335)
Postmarket research (2553)
Preclinical (8160)
Press Release (48)
Prostate cancer (242)
Psychedelics (55)
Radiopharmaceuticals (263)
Rare diseases (881)
Real estate (5253)
Recruiting (68)
Regulatory (24576)
Reports (42)
Research institute (2242)
Resumes & cover letters (418)
Rett syndrome (27)
RNA editing (18)
RSV (73)
Schizophrenia (155)
Series A (227)
Series B (175)
Service/supplier (9)
Sickle cell disease (98)
Special edition (25)
Spinal muscular atrophy (161)
Sponsored (46)
Startups (3283)
State (2)
Stomach cancer (20)
Supply chain (109)
Tariffs (101)
The Weekly (120)
Vaccines (1093)
Venture capital (94)
Weight loss (469)
Women's health (74)
Worklife (22)
Date
Last 7 days (564)
Last 30 days (1896)
Last 365 days (29269)
2026 (2756)
2025 (29694)
2024 (33279)
2023 (37222)
2022 (47705)
2021 (51385)
2020 (48650)
2019 (39200)
2018 (29903)
2017 (30547)
2016 (29175)
2015 (32677)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (776)
Alabama (69)
Alaska (7)
Arizona (246)
Arkansas (11)
Asia (38694)
Australia (6318)
California (10663)
Canada (2788)
China (1050)
Colorado (446)
Connecticut (481)
Delaware (324)
Europe (88693)
Florida (1607)
Georgia (324)
Hawaii (4)
Idaho (42)
Illinois (776)
India (64)
Indiana (452)
Iowa (22)
Japan (418)
Kansas (111)
Kentucky (36)
Louisiana (20)
Maine (74)
Maryland (1322)
Massachusetts (7742)
Michigan (270)
Minnesota (559)
Mississippi (5)
Missouri (114)
Montana (17)
Nebraska (25)
Nevada (111)
New Hampshire (65)
New Jersey (2893)
New Mexico (17)
New York (2767)
North Carolina (1418)
North Dakota (7)
Northern California (5245)
Ohio (286)
Oklahoma (17)
Oregon (37)
Pennsylvania (2068)
Puerto Rico (16)
Rhode Island (33)
South America (1146)
South Carolina (63)
South Dakota (1)
Southern California (4153)
Tennessee (156)
Texas (1593)
United States (37528)
Utah (271)
Virginia (257)
Washington D.C. (77)
Washington State (855)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
629,752 Results for "veloxis pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veloxis Pharmaceuticals to Present at 2025 World Transplant Congress
July 31, 2025
·
4 min read
Bio NC
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
May 30, 2024
·
5 min read
Press Releases
Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
February 26, 2025
·
3 min read
Press Releases
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 29, 2026
·
2 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
Acertis Pharmaceuticals Licenses U.S. Commercial Rights to Licart® from IBSA
January 8, 2026
·
6 min read
Press Releases
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
February 4, 2026
·
5 min read
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
November 21, 2025
·
1 min read
1 of 62,976
Next
